Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

New drug could let some rectal cancer patients skip chemotherapy, radiation and surgery

Some people with rectal cancer may now be able to skip chemotherapy, radiation and surgery. The U.S. Food and Drug Administration (FDA) on Monday approved the immunotherapy Jemperli (dostarlimab-gxly) for certain adults with rectal cancer that hasn't been treated yet.

New drug could let some rectal cancer patients skip chemotherapy, radiation and surgery

We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.

Read the original at medicalxpress.com →

More in Health & Medicine

NAPharm Honours Prof Udeala’s Contribution to Pharmacy Education

Oluchi Chibuzor The Nigeria Academy of Pharmacy (NAPharm) has honoured the late Prof. Oleka Udeala, former Vice-Chancellor of the University of Nigeria, Nsukka (UNN), for his outstanding contributions…

  • Prof. Oleka Udeala, former VP of UNN, honored for pharmacy education contributions
  • Lere Baale, NAPharm President, praised Udeala's historic vice-chancellor role
  • Udeala's legacy includes 1990 IDQ test kit for drug quality assurance

More from Wednesday 21 October →